Frontiers in Medicine | Hepatobiliary Diseases

Original Research

Accepted on 14 Mar 2025

Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors

in Hepatobiliary Diseases

Xiao Cao
Xiao hua Xiao
Pei pei Jiang
Nian Fu

Frontiers in Medicine

doi 10.3389/fmed.2025.1539708

Review

Accepted on 14 Mar 2025

Ferroptosis in NAFLD: Insights and the Therapeutic Potential of Exercise

in Hepatobiliary Diseases

Chang Li
Dongkun Deng
Qingfeng Jiang
Jiaming Shi
Lin Xu
Yufei Liu

Frontiers in Medicine

doi 10.3389/fmed.2025.1462145

Original Research

Published on 14 Mar 2025

The efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: is the alteration of the inflammation index important?

in Hepatobiliary Diseases

Chao Luo
Hua Xiang
Jie Tan

Frontiers in Medicine

doi 10.3389/fmed.2025.1543903

Case Report

Accepted on 13 Mar 2025

Case Report: Fish Bone-Induced Duodenal Perforation Leading to Bile Duct Stones and Portal Vein Thrombosis

in Hepatobiliary Diseases

Yuyi Shi
Xiliang Xu
Yuxu Wang
Wenhao Qu

Frontiers in Medicine

doi 10.3389/fmed.2025.1546707

Clinical Trial

Accepted on 13 Mar 2025

Effectiveness and Risks of Dapagliflozin in Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease with Type 2 Diabetes: A Randomized Controlled Trial

in Hepatobiliary Diseases

Hiroo Fukada
Kazuyoshi Kon
Reiko Yaginuma
Akira Uchiyama
Maki Morinaga
Kei Ishizuka
Kyoko Fukuhara
Hironao Okubo
Satoko Suzuki
Shuko Nojiri

Frontiers in Medicine

doi 10.3389/fmed.2025.1542741

Original Research

Published on 13 Mar 2025

Inter- and Intraobserver variability of attenuation coefficient measurement in innovative ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study

in Hepatobiliary Diseases

Maksym Zhaivoronok
Oleh Dynnyk
Olexandr Livkutnyk
Viktoriia Yerokhovych
Violetta Yuzvenko
Iryna Serednia
Yelizaveta Melnychenko
Nazarii Kobyliak

Frontiers in Medicine

doi 10.3389/fmed.2025.1457960

141 views

Original Research

Accepted on 12 Mar 2025

Exploring the severity and risk factors of non-alcoholic fatty liver disease based on the SAF scoring system

in Hepatobiliary Diseases

Xin Xin Li
Yu Shi Wang
Yu Zi Zhang
Wen Deng
Yaqin Zhang
Weihua Cao
Xin Wei
Xuan Zi Gao
Mei Lin Yao
Lie Shuo Wang

Frontiers in Medicine

doi 10.3389/fmed.2025.1510679

Original Research

Published on 12 Mar 2025

Relationship between albumin-corrected anion gap and non-alcoholic fatty liver disease: a cross-sectional analysis of NHANES 2017–2018

in Hepatobiliary Diseases

Ning Bai
Ting Ying
Dejian Li
Aiguo Liu

Frontiers in Medicine

doi 10.3389/fmed.2025.1518540

125 views

Original Research

Published on 12 Mar 2025

Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018

in Hepatobiliary Diseases

Huang Yu
Tingyi Zhang
Yankun Liu
Wang Wang
Ziyi Guan
Ping Li

Frontiers in Medicine

doi 10.3389/fmed.2025.1538654

141 views

Original Research

Accepted on 11 Mar 2025

The impact of donor liver fibrosis on the outcomes of patients who undergo liver transplant: A Cohort Study from UNOS database

in Hepatobiliary Diseases

Congwen Bian
HanFei Huang
Zhong Zeng

Frontiers in Medicine

doi 10.3389/fmed.2025.1547200

Original Research

Published on 10 Mar 2025

Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma

in Hepatobiliary Diseases

Jing Wang
Meng Song
Jinming Tang
Haoran Yue
Xiaoyang Guo
Zhan Chen
Xiaolan Shen
Mingbo Cao

Frontiers in Medicine

doi 10.3389/fmed.2025.1513233

142 views

Review

Published on 10 Mar 2025

Molecular regulators of alcoholic liver disease: a comprehensive analysis of microRNAs and long non-coding RNAs

in Hepatobiliary Diseases

Lin Zhang
Rongqi Wang
Yuemin Nan
Lingbo Kong

Frontiers in Medicine

doi 10.3389/fmed.2025.1482089

106 views

Review

Published on 07 Mar 2025

Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota

in Hepatobiliary Diseases

Xiaotong Xu
Tong Zhu
Changyou Jing
Minjie Jiang
Yunlai Fu
Fang Xie
Qinghua Meng
Jianjun Li

Frontiers in Medicine

doi 10.3389/fmed.2025.1423780

161 views

Original Research

Accepted on 05 Mar 2025

The gamma-glutamyl transpeptidase to platelet ratio (GPR): A good noninvasive biomarker for predicting for the occurrence and prognosis of patients with hepatitis E virus-related acute liver failure

in Hepatobiliary Diseases

Shuai Zhu
Jun Yuan
Feng Ju
Mengmeng Gu
Ze Xiang
Yan Zhang

Frontiers in Medicine

doi 10.3389/fmed.2025.1573114

Case Report

Published on 05 Mar 2025

Afferent loop obstruction induced by gallstone ileus after Whipple procedure: a case report and literature review

in Hepatobiliary Diseases

Danfeng Shen
Haibin Xu
Peng Chang
Qiang Gu
Hongxing Xu

Frontiers in Medicine

doi 10.3389/fmed.2025.1522046

137 views

Review

Published on 05 Mar 2025

The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies

in Hepatobiliary Diseases

Renee Hernandez
Natasha S. Garcia-Rodriguez
Marco A. Arriaga
Ricardo Perez
Auwal A. Bala
Ana C. Leandro
Vince P. Diego
Marcio Almeida
Jason G. Parsons
Eron G. Manusov

Frontiers in Medicine

doi 10.3389/fmed.2025.1513598

248 views

Navigation group

Articles

Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors

Ferroptosis in NAFLD: Insights and the Therapeutic Potential of Exercise

The efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: is the alteration of the inflammation index important?

Case Report: Fish Bone-Induced Duodenal Perforation Leading to Bile Duct Stones and Portal Vein Thrombosis

Effectiveness and Risks of Dapagliflozin in Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease with Type 2 Diabetes: A Randomized Controlled Trial

Inter- and Intraobserver variability of attenuation coefficient measurement in innovative ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study

Exploring the severity and risk factors of non-alcoholic fatty liver disease based on the SAF scoring system

Relationship between albumin-corrected anion gap and non-alcoholic fatty liver disease: a cross-sectional analysis of NHANES 2017–2018

Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018

The impact of donor liver fibrosis on the outcomes of patients who undergo liver transplant: A Cohort Study from UNOS database

Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma

Molecular regulators of alcoholic liver disease: a comprehensive analysis of microRNAs and long non-coding RNAs

Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota

The gamma-glutamyl transpeptidase to platelet ratio (GPR): A good noninvasive biomarker for predicting for the occurrence and prognosis of patients with hepatitis E virus-related acute liver failure

Afferent loop obstruction induced by gallstone ileus after Whipple procedure: a case report and literature review

The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies